Author name: R A

With over 280 therapies under evaluation, the stem cell therapy market

Health & Safety / /

Roots Analysis is pleased to announce the publication of its recent study, titled, “Global Stem Cells Market: Focus on Clinical Therapies, 2020–2030 (Based on Source (Allogeneic, Autologous); Origin (Adult, Embryonic); Type (Hematopoietic, Mesenchymal, Progenitor); Lineage (Amniotic Fluid, Adipose Tissue, Bone Marrow, Cardiosphere, Chondrocytes, Corneal Tissue, Cord Blood, Dental Pulp, Neural Tissue Placenta, Peripheral Blood, Stromal […]

With over 280 therapies under evaluation, the stem cell therapy market Read More »

The RNA targeting small molecule therapies market

Technology / /

In the recent years, RNA’s potential as a target molecule for small molecules has been widely recognized; as a result, a number of industry players have developed their proprietary technologies for direct and indirect RNA targeting and are actively engaged in the discovery and development of therapies against a wide range of therapeutic disorders  

The RNA targeting small molecule therapies market Read More »

The site management organizations (SMO) market- Roots Analysis

Health & Safety / /

The rapidly growing clinical pipeline and challenges associated with the conduct of clinical trials in a cost and time effective manner, has presented lucrative opportunities for service providers with expertise in clinical trial site management   Roots Analysis has announced the addition of “Site Management Organizations (SMO) Market, 2021 – 2035” report to its list

The site management organizations (SMO) market- Roots Analysis Read More »

Close to 20 companies are currently engaged in the discovery and development of RNA

Health & Safety / /

In recent years, RNA’s potential as a target molecule for small molecules has been widely recognized; a number of players have developed proprietary technologies for direct and indirect RNA targeting, to treat a wide range of clinical conditions   To order this 260+ page report, which features 110+ figures, please visit https://www.rootsanalysis.com/reports/rna-targeting-small-molecule-therapeutics-market.html   The USD

Close to 20 companies are currently engaged in the discovery and development of RNA Read More »

The next generation sequencing kits market is estimated to be worth USD 11.5 billion in 2035, predicts Roots Analysis

Health & Fitness / /

  Owing to its several benefits, next generation sequencing (NGS) kits have emerged as a viable option for various drug developers to overcome the challenges associated with conventional DNA / RNA library preparation methods     Roots Analysis is pleased to announce the publication of its recent study, titled, “Next Generation Sequencing Kits Market, 2021

The next generation sequencing kits market is estimated to be worth USD 11.5 billion in 2035, predicts Roots Analysis Read More »

The Alzheimer’s disease market – Roots Analysis

Research / /

The recent approval of Aduhelm™, an amyloid beta-directed antibody has led to players seeking approval for similar therapies; various interventions are being evaluated for the treatment / management of the inherently complex neurodegenerative disease   Roots Analysis has announced the addition of “Alzheimer’s Disease Market (2nd Edition), 2021-2031” report to its list of offerings.  

The Alzheimer’s disease market – Roots Analysis Read More »

The biopreservation media providers market – Roots Analysis

Health & Fitness / /

To ensure the physiology and integrity of the preserved biological samples, industry stakeholders have developed novel biopreservation media, having a multitude of favorable characteristics for both research and clinical purposes.   Roots Analysis has announced the addition of “Biopreservation Media Providers Market” report to its list of offerings.   Several companies across the globe are

The biopreservation media providers market – Roots Analysis Read More »

Avastin® (Bevacizumab) Biosimilars – Pipeline Review and Partnerships

Medical / /

Roots Analysis has announced the addition of the “Avastin® (Bevacizumab) Biosimilars – Pipeline Review and Partnerships” report to its list of offerings.   Biosimilars of bevacizumab are currently approved / being developed to treat colorectal cancer, non-squamous non-small cell lung cancer, glioblastoma, renal cell carcinoma, and cervical cancer. Experts believe that a strong biosimilar portfolio

Avastin® (Bevacizumab) Biosimilars – Pipeline Review and Partnerships Read More »

The large volume wearable injectors market is estimated to be worth around USD 600 million by 2030, predicts Roots Analysis

Health & Fitness / /

Large Volume Wearable Injectors have made it convenient to self-administer drugs in the home care setting, providing substantial cost benefits, improving medication adherence and reducing the risk of dosing errors, microbial contamination and needle-stick injuries; in fact, these drug delivery devices can prove to be potential vehicles for drug administration in disease outbreaks / pandemics

The large volume wearable injectors market is estimated to be worth around USD 600 million by 2030, predicts Roots Analysis Read More »

The Alzheimer’s disease market is anticipated to grow at an annualized rate of over 13%, till 2030, claims Roots Analysis

Health & Fitness / /

The recent approval of Aduhelm™, an amyloid beta-directed antibody has led to players seeking approval for similar therapies; various interventions are being evaluated for the treatment / management of the inherently complex neurodegenerative disease   Roots Analysis has announced the addition of “Alzheimer’s Disease Market (2nd Edition), 2021-2031” report to its list of offerings.  

The Alzheimer’s disease market is anticipated to grow at an annualized rate of over 13%, till 2030, claims Roots Analysis Read More »